HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chromosomal breakage, endomitosis, endoreduplication, and hypersensitivity toward radiomimetric and alkylating agents: a possible new autosomal recessive mutation in a girl with craniosynostosis and microcephaly.

Abstract
A high frequency of spontaneous chromosomal breakage, endomitosis, endoreduplication and hypersensitivity toward both the alkylating agent Trenimon and the radiomimetric drug bleomycin was observed in phytohemagglutinin-stimulated peripheral lymphocytes from a girl with craniosynostosis, microcephaly, ptosis, bird-like facies, and moderate mental retardation. We also observed abnormal chromosomal spiralization and some aspects of abnormal cellular division. Several fruitless attempts were made to establish a cell line. The parents were consanguineous, supporting the existence of a new, rare, autosomal, recessive condition in man. The mutation might involve a gene involved in DNA repair and/or regulation of the mitotic cycle.
AuthorsN Tommerup, E Mortensen, M H Nielsen, R D Wegner, D Schindler, M Mikkelsen
JournalHuman genetics (Hum Genet) Vol. 92 Issue 4 Pg. 339-46 (Oct 1993) ISSN: 0340-6717 [Print] Germany
PMID7693575 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Bleomycin
  • DNA
  • Triaziquone
Topics
  • Adult
  • Bleomycin (adverse effects)
  • Chromosome Aberrations
  • Consanguinity
  • Craniosynostoses (genetics)
  • DNA (biosynthesis)
  • Drug Hypersensitivity (etiology, genetics)
  • Female
  • Humans
  • Infant
  • Lymphocytes
  • Male
  • Microcephaly (genetics)
  • Mitosis (genetics)
  • Multigene Family
  • Mutation
  • Triaziquone (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: